Kirkland advised Lilly Asia Ventures on the deal. Lilly Asia Ventures (LAV) completed the final closing of its sixth USD life sciences funds, LAV Fund VI, L.P. and...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here